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THE JOHN WESLEY POWELL STUDENT RESEARCH CONFERENCE. APRIL 1996 
Oral Presentation 1.5 
EFFECTS OF ADRENERGIC AND CHOLINERGIC 
PHARMACOLOGICAL CHALLENGES ON RADIAL ARM MAZE 
PERFORMANCE IN MALE RATS WITH 192 IGG SAPORIN INDUCED 
LESIONS OF THE BASAL FOREBRAIN 
Lesley Hickman and Wayne Dornan*, Dept. of Psychology, lWU 
Alzheimer's Disease (AD) is a neurodegenerative disease that currently 
affiicts over 4 million people in the United States, with roughly 100,000 new 
cases reported every year. This disorder causes gradual deterioration of 
cognitive functions, particularly learning and memory. Pathologically, AD is 
manifested by the appearance of neuritic plaques and neurofibrillary tangles, 
and also by the progressive deterioration of the cortex and septohippocampal 
pathway, which supplies the hippocampus and cortex with cholinergic fibers. 
Currently, there is no effective treatment for this disease. Development of 
drug therapies is hindered by the lack of an animal model of AD that mimics 
both the pathological and behavioral deficits present in AD. The goal of our 
lab is to create such a model in the male rat by lesioning the areas that 
supply acetylcholine, thus imitating the cholinergic degeneration seen in AD. 
These areas are the nucleus basalis magnocellularis (NBM), which innervates 
the cortex and amygdala, and the medial septal area (MSA), which 
innervates the hippocampus. We used a highly specific neurotoxin called 192-
IgG-Saporin, a toxin coupled to an antibody directed against a receptor found 
only on cholinergic neurons. The lesions appeared to have no effect on 
retention of a previously learned radial arm maze (RAM) memory task (5 
arms baited), or acquisition of a task involving a 5-minute delay, when 
compared to controls who had received identical injections of the vehicle. 
Because the lack of effect may be due either to compensation by the brain to 
the loss of these fibers or incomplete lesions of the MSA and NBM, we 
challenged the cholinergic system and the adrenergic system with 
scopolamine, a muscarinic receptor antagonist, and an adrenergic antagonist 
and assessed the effects of these injections using the same RAM delay task. 
The results of this study will be presented at the conference. 
